Patent · US Expired

Substituted anthranilic acids, their use as a medicament or diagnostic, and medicament comprising them, and a pharmaceutical combination preparation containing a sodium/hydrogen exchange (NHE) blocker

US6593352B2 · kind B2 · utility

27Cited by

3References

16Claims

0Family size

Assignee

Aventis Pharma Deutschland GmbH · DE

Inventors

Andreas Weichert · Egelsbach, DE
Hans-Willi Jansen · Niedernhausen, DE
Heinz-Werner Kleemann · Bischofsheim, DE
Hans-Jochen Lang · Hofheim, DE
Hartmut Rutten · Idstein, DE

Key dates

Filing date	Dec 6, 2001
Grant date	Jul 15, 2003
Priority date	—
Expiry date	Dec 6, 2021

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D333/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Substituted anthranilic acids of the formula I their use as a medicament or diagnostic, and medicament comprising them, and a pharmaceutical combination preparation containing a sodium/hydrogen exchange (NHE) blocker.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.